Literature DB >> 3657909

In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.

C N Okeke1, H C Gugnani.   

Abstract

The in vitro sensitivity (minimum inhibitory concentrations; MICs) of 42 environmental isolates of pathogenic dematiaceous fungi to 7 azole compounds, viz. thiabendazole, ketoconazole, miconazole, econazole bifonazole, Bay n 7133, Bay 1 9139 and phenylpropyl-morpholine derivative, Ro14-4767/002 was studied by an agar dilution method using Emmon's Sabouraud dextrose agar (ESDA) as the culture medium. The isolates of Fonsecaea pedrosoi, Cladosporium carrionii, Exophiala jeanselmei and Ramichloridium subulatum were most sensitive to bifonazole with mean MICs of 0.06 microgram/ml or less; Phialophora verrucosa had an MIC of 0.05 microgram/ml to ketoconazole and Ro14-4767/002, respectively. Ochroconis sp had an MIC of 0.025 microgram/ml to Ro14-4767/002 and Cladosporium tennuisimum 0.39 microgram/ml to ketoconazole. Econazole and thiabendazole also showed good antifungal activity. The fungi were relatively resistant to the more recently developed azoles, viz. Bay n 7133 and Bay 1 9139, the later failing to inhibit C. tennuisimum at a concentration of 100 micrograms/ml. The minimum fungicidal concentrations (MFC) of the drugs were mostly within 2 to 8 fold of the MICs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3657909     DOI: 10.1007/bf00437440

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

1.  [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)].

Authors:  I Haller
Journal:  Mykosen       Date:  1979-12

2.  Chromomycosis. Treatment with thiabendazole.

Authors:  M A Bayles
Journal:  Arch Dermatol       Date:  1971-11

3.  A case of chromomycosis treated with thiabendazole.

Authors:  J E Ollé-Goig; J Domingo
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

4.  Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole.

Authors:  L C Cucé; E L Wroclawski; S A Sampaio
Journal:  Int J Dermatol       Date:  1980-09       Impact factor: 2.736

5.  Chromoblastomycosis treatment with ketoconazole.

Authors:  E I McBurney
Journal:  Cutis       Date:  1982-12

6.  Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.

Authors:  M L Corrado; M Kramer; M Cummings; R H Eng
Journal:  Sabouraudia       Date:  1982-06

7.  Treatment of chromoblastomycosis with high local concentrations of amphotericin B.

Authors:  D A Whiting
Journal:  Br J Dermatol       Date:  1967-06       Impact factor: 9.302

8.  In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.

Authors:  S Shadomy; A Espinel-Ingroff; T M Kerkering
Journal:  Sabouraudia       Date:  1984

9.  Antifungal activity in vitro of Ro 14-4767/002, a phenylpropyl-morpholine.

Authors:  A Polak
Journal:  Sabouraudia       Date:  1983-09

10.  Chromomycosis caused by Philaphora pedrosoi in eastern Nigeria.

Authors:  H C Gugnani; J U Egere; A V Suseelan; A N Okoro; W I Onuigbo
Journal:  J Trop Med Hyg       Date:  1978-10
View more
  3 in total

1.  In vitro susceptibility of Trichophyton rubrum isolates to griseofulvin and tioconazole. Induction and isolation of a resistant mutant to both antimycotic drugs. Mutant of Trichophyton rubrum resistant to griseofulvin and tioconazole.

Authors:  A L Fachin; C M Maffei; N M Martinez-Rossi
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

2.  In vitro activity of seven azole compounds against some clinical isolates of non-dermatophytic filamentous fungi and some dermatophytes.

Authors:  C A Oyeka; H C Gugnani
Journal:  Mycopathologia       Date:  1990-06       Impact factor: 2.574

3.  Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis.

Authors:  Yi Sun; Wei Liu; Zhe Wan; Xiaohong Wang; Ruoyu Li
Journal:  Mycopathologia       Date:  2010-08-29       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.